Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Department of Medicine (4)
- Aged (1)
- Algorithms (1)
- Blood Glucose (1)
- Body Mass Index (1)
-
- Clinical Nutrition Services (1)
- Coronary Artery Bypass (1)
- Critical Care (1)
- Department of Medicine Faculty (1)
- Diabetes Mellitus (1)
- Diabetic Angiopathies (1)
- Drug Administration Schedule (1)
- Ectopic ACTH Syndrome (1)
- Female (1)
- Glomerular Filtration Rate (1)
- Glycosylated (1)
- Hematocrit (1)
- Hemoglobin A (1)
- Humans (1)
- Hyperparathyroidism (1)
- Hypoglycemia (1)
- Hypoglycemic Agents (1)
- Insulin (1)
- Insulin Infusion Systems (1)
- Male (1)
- Metastatic Neuroendocrine Pancreatic Gastrinoma (1)
- Middle Aged (1)
- Postoperative Period (1)
- Retrospective Studies (1)
Articles 1 - 5 of 5
Full-Text Articles in Medicine and Health Sciences
Ectopic Acth Syndrome Due To Men-I Associated Metastatic Neuroendocrine Pancreatic Gastrinoma In A 22 Year Old Female Without Hyperparathyroidism: Diagnostic And Therapeutic Challenges, Vasudev Magaji, Mansoor Tanwir, Mary Korytkowski, Sue Challinor
Ectopic Acth Syndrome Due To Men-I Associated Metastatic Neuroendocrine Pancreatic Gastrinoma In A 22 Year Old Female Without Hyperparathyroidism: Diagnostic And Therapeutic Challenges, Vasudev Magaji, Mansoor Tanwir, Mary Korytkowski, Sue Challinor
Vasudev G Magaji MD, MS
Introduction: Ectopic ACTH production due to malignant tumors is a rare cause of Cushing's syndrome (CS). Diagnosis and treatment of such patients can be challenging. Case: 22 year old female with recent onset fatigue, weight gain, polyuria, polydipsia, presented with melena and hypotension. She had cushingoid facies, acne, central obesity, muscle weakness and purple striae. Labs showed: Cortisol 56 µg/dl (5-15), 24 hour UFC >1000 µg/24hr (5-50), Cortisol after 1mg Dexamethasone suppression 54 µg/dl (Learning points: When evaluating patients with suspected ectopic ACTH production, independent review of radiologic imaging should be done to avoid being misled by prior reports. EUS …
Comparison Of Insulin Infusion Protocols Targeting 110-140 Mg/Dl In Patients After Cardiac Surgery., Vasudev Magaji, Shriddha Nayak, Amy Donihi, Lauren Willard, Srinivasa Jampana, Parachur Nivedita, Raymond Eder, Jann Johnston, Mary Korytkowski
Comparison Of Insulin Infusion Protocols Targeting 110-140 Mg/Dl In Patients After Cardiac Surgery., Vasudev Magaji, Shriddha Nayak, Amy Donihi, Lauren Willard, Srinivasa Jampana, Parachur Nivedita, Raymond Eder, Jann Johnston, Mary Korytkowski
Vasudev G Magaji MD, MS
BACKGROUND: Continuous intravenous insulin infusion (CII) following coronary artery bypass graft (CABG) surgery reduces postoperative complications and hospitalization duration. Because of limited data evaluating outcomes of CII with revised glycemic targets (110-140 mg/dL) in cardiac surgery, this study compared efficacy and safety of two different CII protocols having revised targets. SUBJECTS AND METHODS: This is a retrospective study comparing two different protocols between August 2009 and March 2010. Protocol 1 consists of four algorithms, and Protocol 2 is a table to adjust CII. Blood glucose (BG) and CII rates were recorded for 48 h postoperatively or CII discontinuation. Efficacy was …
Efficacy And Safety Of Continuous Insulin Infusion Protocols With Glycemic Targets Of 110-140 Mg/Dl In Patients With And Without Diabetes Following Cardiac Surgery, Shriddha Nayak, Vasudev Magaji, Amy Donihi, Lauren Willard, Srinivasa Jampana, Parachur Nivedita, Raymond Eder, Jann Johnston, Mary Korytkowski
Efficacy And Safety Of Continuous Insulin Infusion Protocols With Glycemic Targets Of 110-140 Mg/Dl In Patients With And Without Diabetes Following Cardiac Surgery, Shriddha Nayak, Vasudev Magaji, Amy Donihi, Lauren Willard, Srinivasa Jampana, Parachur Nivedita, Raymond Eder, Jann Johnston, Mary Korytkowski
Vasudev G Magaji MD, MS
No abstract provided.
Inpatient Management Of Hyerglycemia And Diabetes, Vasudev Magaji, Jann Johnston
Inpatient Management Of Hyerglycemia And Diabetes, Vasudev Magaji, Jann Johnston
Vasudev G Magaji MD, MS
No abstract provided.
Short Term Unblinded Continuous Glucose Monitoring For Long Term Glucose Control, Vasudev Magaji, Adam Akers, Jann Johnston
Short Term Unblinded Continuous Glucose Monitoring For Long Term Glucose Control, Vasudev Magaji, Adam Akers, Jann Johnston
Vasudev G Magaji MD, MS
No abstract provided.